Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus
03 janv. 2025 11h07 HE
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Precision Medicine in Oncology Collaboration and Licensing Deals Analysis Report 2024 with Directory of 821 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target
03 janv. 2025 10h59 HE
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report...
Gene Therapy Agreements Analysis Report and Directory 2024: Comprehensive Listing of 740 Deals Announced Since 2016
17 juil. 2024 05h31 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Therapy Collaboration and...
Global Paternity & Relationship Testing Services Market Research 2024: Increased Competition Lowers Price, Cultural Shifts Changing Meaning of Family, Ancestry Influencing Changing Attitudes
15 juil. 2024 04h47 HE
|
Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services: Global Market Forecast by Application and by Product with Executive and Consultant Guides" report has...
GeneType to Enter Canadian and New Zealand Markets
09 juil. 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType to Enter Canadian and New Zealand Markets
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
25 juin 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
21 juin 2024 08h00 HE
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
05 juin 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
GeneType and Humanise Health host “Know Your Risk” Event
23 mai 2024 08h00 HE
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
Viral Vector Collaboration, R&D, and Licensing Deals Trends Report 2024 with Directory of 396 Agreements Signed Since 2016
07 mai 2024 09h04 HE
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Viral Vector Collaboration and...